Center for Cardiovascular Biology
In this Section
Congenital heart defects (CHD) are the leading cause of infant mortality associated with birth defects and can result in chronic disability (both physical and mental), morbidity, and increased health care costs.
New areas of cardiac therapy such as stem cell therapy are being rapidly developed for adult heart disease. One of our goals is to make progress in understanding how stem cells can be directed toward cardiac regeneration and repair of the infant heart with CHD.
We have active programs in research that work toward our overall vision of enhancing the diagnosis and treatment of infants and children with Congenital Heart Defects.
The goal of the Center is to integrate basic science, translational clinical research with a focus on three areas: